Top compounds associated with response to RALGDS

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	UNC0638:navitoclax (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.25	2e-10
mRNA	BRD-A02303741:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.23	2e-09
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.19	2e-08
mRNA	tipifarnib	CTRPv2	pan-cancer	AAC	0.19	3e-08
mRNA	XMD14-99	GDSC1000	pan-cancer	AAC	0.19	3e-08
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.21	5e-08
mRNA	GSK1070916	GDSC1000	pan-cancer	AAC	0.18	8e-08
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.21	1e-07
mRNA	CH5424802	GDSC1000	pan-cancer	AAC	0.19	2e-07
mRNA	XMD13-2	GDSC1000	pan-cancer	AAC	0.17	2e-07

Download CSV